Edition:
United Kingdom

Erytech Pharma SA (ERYP.OQ)

ERYP.OQ on NASDAQ Stock Exchange Global Select Market

8.00USD
22 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.00
Open
$8.00
Day's High
$8.00
Day's Low
$8.00
Volume
52
Avg. Vol
1,019
52-wk High
$23.50
52-wk Low
$5.54

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 1.86 1.86 1.86 --
Quarter Ending Jun-19 1 1.86 1.86 1.86 --
Year Ending Dec-19 2 5.47 7.40 3.54 5.22
Earnings (per share)
Quarter Ending Mar-19 1 -0.38 -0.38 -0.38 --
Quarter Ending Jun-19 1 -0.41 -0.41 -0.41 --
Year Ending Dec-19 3 -3.24 -1.75 -4.67 -3.09
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 147.99 49.93
P/E Low - Last 5 Yrs. -- 47.78 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) -- 10.16 5.27
Price to Tangible Book (MRQ) -- 13.82 6.78
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions -- 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.05 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 5.88
Sales - 5 Yr. Growth Rate -- 22.77 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.88 47.26
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) -- 3.43 3.08
LT Debt to Equity (MRQ) -- 18.73 11.39
Total Debt to Equity (MRQ) -- 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.79
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.24 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -- -175.21 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.84 8.61
Net Profit Margin (TTM) -- -181.94 3.31
Net Profit Margin - 5 Yr. Avg. -- -137.24 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,651,352 844,195,039
Net Income/Employee (TTM) -- 652,648 100,058,867
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) -- 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -- 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.86 15.88
Return on Equity (TTM) -- 10.14 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.67%
# of Holders: 8
Total Shares Held: 2,631,032
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.